Loading clinical trials...
Loading clinical trials...
A 3-way, Crossover, Randomized, Open-label Study in Healthy Subjects Comparing the Bioavailability of Belumosudil (KD025) Tablets in Fed and Fasted States and Relative Bioavailability of Tablets and Capsules in the Fed State
Conditions
Interventions
Belumosudil Tablet
Belumosudil Capsule
Locations
1
United Kingdom
Quotient Clinical Limited
Ruddington Nottingham, United Kingdom
Start Date
September 1, 2015
Primary Completion Date
October 12, 2015
Completion Date
October 12, 2015
Last Updated
May 25, 2022
NCT07063173
NCT07345130
NCT07046975
NCT06882681
NCT06641245
NCT06177483
Lead Sponsor
Kadmon Corporation, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions